Skip to main content

What the FDA labels say about taking them together

Doravirine and efavirenz

Doravirine's FDA label of July 8, 2026 names efavirenz in its drug interactions section; the efavirenz label PlainMeds reads does not name doravirine. The doravirine label: “Use with efavirenz, etravirine, or nevirapine is not recommended.”

Check it at the source: the doravirine FDA label on DailyMed (effective July 8, 2026, Merck Sharp & Dohme LLC); the efavirenz FDA label on DailyMed (effective March 31, 2024, Cipla USA Inc.).

What does the doravirine label say about efavirenz?

Doravirine label, drug interactions

Concomitant Drug Class/Drug Name: efavirenz etravirine nevirapine; Effect on Concentration: ↓ doravirine; Clinical Comment: Use with efavirenz, etravirine, or nevirapine is not recommended.

Source: FDA drug label (PIFELTRO), Merck Sharp & Dohme LLC, effective July 8, 2026 (SPL set 76ce1f00-28c0-4314-bd2c-d473fe3d0970), via openFDA; the full label on DailyMed

What does the efavirenz label say about doravirine?

Efavirenz's label (effective March 31, 2024) does not name doravirine in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Efavirenz), Cipla USA Inc., effective March 31, 2024 (SPL set 92603fa5-7a2c-4bfb-9a70-aadb4fba952c), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Doravirine generic labelers
5Efavirenz generic labelers
DoravirineEfavirenz
Labeled forHIVHIV
Boxed warningNoNo
Pharmacy cost (NADAC)$60.79 per tablet 100 mg tablet$1.28 per tablet 600 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?